Publications
Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 11980991
Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141
Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, Johnson RL, Cox AD, Philips MR. Ras signalling on the endoplasmic reticulum and the Golgi. Nature cell biology. 2002. PMID: 11988737
Moasser MM, Rosen N. The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer. Breast cancer research and treatment. 2002. PMID: 12088116
Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010
Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010
Kohlwes RJ, Chou CL. A curriculum in medical economics for residents. Academic medicine : journal of the Association of American Medical Colleges. 2002. PMID: 12010725
Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. The Journal of urology. 2002. PMID: 11956415
Rini BI, Small EJ. Prostate cancer update. Current opinion in oncology. 2002. PMID: 11981273
Park JW. Liposome-based drug delivery in breast cancer treatment. Breast cancer research : BCR. 2002. PMID: 12052251
Huang F, Stremlau M. Training to think globally. Nature. 2002. PMID: 11948324
Theodosiou A, Ashworth A. Differential effects of stress stimuli on a JNK-inactivating phosphatase. Oncogene. 2002. PMID: 11948422
Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002. PMID: 11948130
Warren M, Smith A, Partridge N, Masabanda J, Griffin D, Ashworth A. Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutations. Human molecular genetics. 2002. PMID: 11929857
Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2002. PMID: 11996478
Merad M, Sugie T, Engleman EG, Fong L. In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood. 2002. PMID: 11861283
Robibaro B, Stedman TT, Coppens I, Ngô HM, Pypaert M, Bivona T, Nam HW, Joiner KA. Toxoplasma gondii Rab5 enhances cholesterol acquisition from host cells. Cellular microbiology. 2002. PMID: 11906451
Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A. Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation. EMBO reports. 2002. PMID: 11850397
Basso AD, Solit DB, Munster PN, Rosen N. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene. 2002. PMID: 11850835
Harmon EB, Ko AH, Kim SK. Hedgehog signaling in gastrointestinal development and disease. Volume 2 of Issue 1 Current molecular medicine. 2002. PMID: 11898849